About

Launched in 2016, Israel Haifa based Paragate Medical is an innovative device company, aiming to revolutionize the heart failure epidemic management by shifting the weight of chronic disease treatment out of the hospital towards home-based care.

Our Mission is to reduce fluid overload in Chronic Heart and Kidney Failure patients, the greatest burden on the healthcare system.

Prevention Requires Action. Paragate is set to break the vicious cycle for fluid overload and provide a chronic, active solution for this chronic condition.

Our Team

Hernan_Altman

Hernan Altman

Member of Board

Nizar_Mishael_image

Nizar Mishael

CFO

Micha_Oestereich_image

Micha Oestereich

VP QA/RA

Dr._Amir_Toren_image

Dr. Amir Toren

VP Business Development

Nitai_Hanani_image

Nitai Hanani

CEO & Co-founder

Dr._Yair_Feld_image

Dr. Yair Feld

Medical Director & Founder

Zohar_Gendler_image

Zohar Gendler

Chairman

Hernan_Altman

Hernan Altman

Member of Board

Over 20 years’ experience in the MedDev industry – working with start-ups, large companies and global corporations. He fulfilled roles in R&D, IP, Quality, Clinical and Regulatory Affairs, leading multiple projects from early stages through clinical trials.

He is involved in over 30 patents and applications in medical imaging, detectors, neural stimulation and invasive cardiology. Former senior director R&D in Edwards life science, leading cutting-edge development of structural heart devices (SapienIII). Prior to that served as VP R&D and Application in Brainsgate, were he led negotiation and execution of IDE trial of over 800 patients, and department manager of system engineering at GE. Hernan brings strong skillset for taking medical devices from pipeline development through clinical trials and regulation.

Nizar_Mishael_image

Nizar Mishael

CFO

Nizar served as the Managing Partner and Chief Financial Officer for New Generation Technology incubator (NGT), where he supported over ten portfolio companies.

He managed the finances of these companies with strong leadership, closely following the budget, making sure the companies receive their full government money, and ensuring they set goals and achieve what they should (and when) with their funds. He has also taken an active role with follow-on funding and handling complex investment transactions. Previously, Nizar was the Chairman and Director of Positive Care. He holds Certified Public Accountant license with Greenberg & Shneor and holds a M.B.A. from Tel Aviv University.

Micha_Oestereich_image

Micha Oestereich

VP QA/RA

Over 20 years of multi-disciplinary experience in the area of managing, product development, regulatory and clinical research in the medical device industry.

Micha has strong focus on regulatory affairs of medical devices and served as director of Regulatory Affairs in companies like Ornim, Mennen Medical, Neovasc and Medinol. He also holds a private regulatory consultancy firm, advising vast number of Israeli medical devices companies with vast number of regulatory submissions to FDA, CE and other jurisdictions. Micha hold BSc in Ophthalmic Science from Bar-Ilan and Haifa University and MA in life sciences from the University of Haifa.

Dr._Amir_Toren_image

Dr. Amir Toren

VP Business Development

Acts as CTO and VP Business Development at NGT. Amir brings extensive experience in leading R&D, regulation and clinical affairs of various companies, including more than 10 years in managing medial devices and biotech companies. Amir has a PhD in biochemistry and biotechnology.

Nitai_Hanani_image

Nitai Hanani

CEO & Co-founder

Over thirteen years of experience in cardiovascular and neuromodulation medical devices field in various R&D, engineering and management positions, from which seven with Enopace Biomedical – pioneering the conceptualization and development of intravascular neurostimulation device for treatment of heart failure.

Involved with companies in the fields of stroke treatment, renal denervation, peripheral interventional, acute kidney injury and ventilation monitoring. B.Sc., M.Sc. in Biomedical Engineering, Technion-IIT, Haifa, Israel Graduate project spun-off as startup (Pneumedicare) for ventilation monitoring. Conducted research in Cardiac Resynchronization Therapy, awarding him as young investigator award of the Israeli Society for Heart Research (ISHR).

Dr._Yair_Feld_image

Dr. Yair Feld

Medical Director & Founder

Dr. Yair Feld is a practicing cardiologist in Rambam Healthcare Campus. Yair has over 20 years of experience in managing life science companies and leading innovative research and development projects.
He founded several medical technology companies among which Nephera Ltd., Corassist Cardiovascular and Proarc. He has 10 years of experience in leading innovative research and development projects. Yair received his MD and PhD (physiology and biophysics) from the Technion-Israel Institute of Technology, as well as a BA is Physics from the University of Tel-Aviv.

Zohar_Gendler_image

Zohar Gendler

Chairman

CEO and managing partner of NGT3 Incubator. Former CEO and director of Beta-O2 Technologies (a biomedical company which developed proprietary Implantable bio-artificial pancreas) for a period of 8 years, brought the company to one of the world leaders positioning in the area.

Served as CEO of the Technion Entrepreneurial Incubator (TEIC) for a period of 11 years. Led the establishment and investment in more than 40 companies, such as Prolor Biotech (Opko), Mazor Robotics (Medtronic), Corindus (Siemens), ReWalk (NASDAQ: RWLK) and many others. Gained a wide range of experience in identifying new technologies and in establishing, directing, and creating value for technology-based start-up companies. M.Sc. in material engineering, B.Sc. in physics, and MBA, all from the Technion, Israel Institute of Technology.

Scientific Advisory Board

Piotr_Ponikowski

Prof. Piotr Ponikowski

SAB Member

Maria_Rosa_Costanzo

Dr. Maria Rosa Costanzo

SAB Member

Uni_Elkayam

Prof. Uni Elkayam

SAB Member

Piotr_Ponikowski

Prof. Piotr Ponikowski

SAB Member

Piotr Ponikowski MD, PhD, FESC, is Head of the Department of Heart Diseases, Wroclaw Medical University and Head of the Cardiology Department at the Center for Heart Diseases at 4th Military Hospital, Wroclaw, Poland.

Former president of the European Heart Failure Association and Chair of the European Guidelines for HF management. His research interests mainly include heart failure (HF), coronary artery disease and cardiac arrhythmias. He has been involved in numerous research projects, such as the benefits of physical rehabilitation in patients with chronic HF, assessment of metabolic derangements in HF (with special interest in iron deficiency), evaluation of reflex control in the cardiorespiratory system in order to optimize assessment and management of patients with HF. He has been involved in numerous clinical trials as main investigator, member of international steering committees, endpoint committees and advisory boards.

Maria_Rosa_Costanzo

Dr. Maria Rosa Costanzo

SAB Member

Dr Costanzo Maria Rosa Costanzo, MD, FESC, FACC, FHSA, is a Worldwide Leading Researcher in Ultrafiltration Therapy. She is Medical Director of the Heart Failure Program with Midwest Heart Specialists, and Medical Director of the Edward Center for Advanced Heart Failure in Naperville, Illinois.

Dr Costanzo was Director of the Loyola University Chicago Heart Failure and Cardiac Transplant Program between 1988 and 1994, and of the Rush Heart Failure and Cardiac Transplant Program between 1994 and 2001. She is a Member of the Research Committee of the Heart Failure Society of America (HFSA). Between 1995 and 2000, Dr Costanzo was Editor in Chief of the Journal of Heart and Lung Transplantation. She has published more than 150 peer-reviewed manuscripts and is the author of numerous review papers, monographs, and book chapters.

Uni_Elkayam

Prof. Uni Elkayam

SAB Member

Uri Elkayam, MD FHSA, is a Professor of Medicine and a Professor of Obstetrics and Gynecology at the University of Southern California. He is a nationally and internationally known expert in heart failure and heart disease in pregnancy.

Dr Elkayam is a past member of the executive council of the Heart Failure Society of America and the chairman of its corporate affairs committee. He is a present or past editorial board member of the Journal of the American College of Cardiology, American Journal of Cardiology, Journal of Cardiac Failure, Heart Failure, Heart Failure Reviews, Journal of Preventive Cardiology and Cardiology in Review.

Contact Us